Aptose Biosciences Q2 EPS $(2.27) Misses $(2.01) Estimate
Portfolio Pulse from Benzinga Newsdesk
Aptose Biosciences reported Q2 losses of $2.27 per share, missing the analyst consensus estimate of $2.01 by 12.94%. This represents a 37.58% increase in losses compared to the same period last year.
August 10, 2023 | 8:27 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Aptose Biosciences reported larger than expected losses for Q2, which could negatively impact investor sentiment.
Aptose Biosciences reported a larger than expected loss for Q2, missing analyst estimates by 12.94%. This could lead to a decrease in investor confidence and a potential drop in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100